معرفی
Dr. David Chan is a Senior Lecturer at the Sydney Medical School, affiliated with the Northern Clinical School at the University of Sydney. His work bridges teaching and research, focusing on neuroendocrine tumors (NENs), medical imaging, and cancer biomarkers.
- Current affiliations: University of Sydney, Sydney Medical School, Northern Clinical School
- Academic role: Senior Lecturer (Teaching and Research)
Dr. Chan’s research centers on neuroendocrine tumors, particularly their imaging-based biomarkers and therapeutic outcomes. He has pioneered the NETPET score, a dual PET/CT tool for predicting survival in high-grade GEP-NENs, and explored the role of metabolic tumor volume in PRRT efficacy. His work spans colorectal cancer, pancreatic cancer, and immunotherapy combinations, with a focus on prognostic imaging and inflammatory markers like NLR/PLR.
Recent publications highlight his contributions to multicenter trials on PRRT, case series on carcinoid heart disease, and systematic reviews of targeted therapies. His 2025 studies include hypoxia PET imaging in metastatic NENs and clinical trials on biomarker-driven treatment strategies.
Scientific Awards:
- NHMRC Investigator Grant (2019)
- Sydney Vital Translational Cancer Research Scholarship Top Up (2019)
Dr. Chan mentors PhD student Krishna KOTECHA and has led grants on quantitative dual PET analysis and 18F-FMISO PET in NENs. His clinical trials (NET-001, NET-002) and consensus guidelines for hormonal crisis management in NENs underscore his leadership in translational oncology.
